Development of a new preclinical model of Parkinson’s disease

被引：0
|
作者：
Alexandra Le Bras
机构：
[1] Lab Animal,
来源：
Lab Animal | 2020年 / 49卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 219
相关论文
共 50 条
  • [41] Longitudinal Assessment Of Dopamine Progenitor Cell Engraftment In A Preclinical Model Of Parkinson's Disease
    Goggi, J.
    Liao, M.
    Qiu, L.
    Li, Z.
    Oh, S.
    Luthra, S.
    Shingleton, W.
    Robins, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S143 - S143
  • [42] Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinson's Disease
    Galindo, Maria F.
    Solesio, Maria E.
    Atienzar-Aroca, Sandra
    Zamora, Maria J.
    Jordan Bueso, Joaquin
    PARKINSONS DISEASE, 2012, 2012
  • [43] MPTP Mouse Model of Preclinical and Clinical Parkinson’s Disease as an Instrument for Translational Medicine
    Eduard R. Mingazov
    Gulnara R. Khakimova
    Elena A. Kozina
    Alexei E. Medvedev
    Olga A. Buneeva
    Ara S. Bazyan
    Michael V. Ugrumov
    Molecular Neurobiology, 2018, 55 : 2991 - 3006
  • [44] Impairment to Cognitive Functions in Wistar Rats in a Model of the Preclinical Stage of Parkinson’s Disease
    Abdurasulova N.N.
    Ekimova I.V.
    Chernyshev M.V.
    Matsulevich A.V.
    Pastukhov Y.F.
    Neuroscience and Behavioral Physiology, 2020, 50 (4) : 439 - 450
  • [45] Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease
    Paris, Irmgard
    Cardenas, Sergio
    Lozano, Jorge
    Perez-Pastene, Carolina
    Graumann, Rebecca
    Riveros, Alejandra
    Caviedes, Pablo
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2007, 12 (02) : 125 - 134
  • [46] Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testing
    Cesaroni, Valentina
    Blandini, Fabio
    Cerri, Silvia
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (10) : 837 - 851
  • [47] Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease
    Li, Xiang-Yun
    Mei, Guang-Hai
    Dong, Qiang
    Zhang, Yu
    Guo, Zhuang-Li
    Su, Jing-Jing
    Tang, Yu-Ping
    Jin, Xue-Hong
    Zhou, Hou-Guang
    Huang, Yan-Yan
    PARKINSONS DISEASE, 2015, 2015
  • [48] Preclinical signs of Parkinson's disease: A possible association of Parkinson's disease with skin and hair features
    Juceviciute, Neringa
    Banaityte, Indre
    Vaitkus, Antanas
    Balnyte, Renata
    MEDICAL HYPOTHESES, 2019, 127 : 100 - 104
  • [49] The contribution of neuroirnaging to the preclinical diagnosis of Parkinson's disease
    Piccini, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 337 - 337
  • [50] PARKINSON'S DISEASE: ADVANCES IN PRECLINICAL SCREENING MODELS
    Khan, Shaheen
    Ansari, Imtiyaz
    Singh, Chandrashekhar
    Bamne, Falak
    Kapadia, Salman
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (10): : 4866 - 4873
12345